McCormick Growth Trends Rest on Innovation and Cost Savings Momentum

Earnings
โดย Zacks Investment Research·Read original
Summary · why it matters

McCormick & Company is leaning on health-focused innovation, cost savings, and portfolio expansion to drive long-term growth, even as consumer segment volumes remain negative. The company's Comprehensive Continuous Improvement program helped expand adjusted gross margin by 270 basis points to 40.2% in the latest quarter, while adjusted operating income rose 30.1% to $336.4 million. The acquisition of a controlling 75% stake in McCormick de Mexico contributed 12.3 percentage points to total sales growth, and the proposed Unilever Foods combination is expected to generate about $600 million in annual run-rate cost synergies. Flavor demand is benefiting from at-home cooking and better-for-you trends, with a majority of second-quarter briefs tied to health and wellness innovation. The stock currently carries a Zacks Rank #4 (Sell), reflecting cautious consumer spending and the need for better volume execution.

Impact on stocks 4

Consumer Staples▲ · 4 stocks
McCormick & Company Incorporated
MKC
▲ PositiveCapitalrelevance

Cost savings and margin expansion (CCI program) drove adjusted gross margin up 270 bps and operating income up 30.1%.

Unilever PLC
UNLYD
▲ PositiveCapitalrelevance

Proposed Unilever Foods combination expected to generate ~$600M annual run-rate cost synergies.

Off-coverage companies 1

McCormick de MexicoPrivate▲ Positive
Demandrelevance

Acquisition of controlling 75% stake contributed 12.3 percentage points to total sales growth.

© 2026 MarketDXNews